Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07121972) titled 'Mirai-MRI: Validation of AI Models for Breast Cancer Risk' on Aug. 6.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Screening. Masking: None (Open Label).
Primary Sponsor: University of California, San Francisco
Condition:
Cancer Risk
Breast Cancer Risk
Intervention:
Procedure: Magnetic resonance imaging (MRI)
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: August 10, 2025
Target Sample Size: 400
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07121972
P...